These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 15151941

  • 1. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics.
    Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P.
    Ann Oncol; 2004 Jun; 15(6):863-9. PubMed ID: 15151941
    [Abstract] [Full Text] [Related]

  • 2. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 4. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
    Boggan JC, Walmer DK, Henderson G, Chakhtoura N, McCarthy SH, Beauvais HJ, Smith JS.
    Sex Transm Dis; 2015 Nov 09; 42(11):655-9. PubMed ID: 26462192
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF, Du H, Wang C, Huang X, Qu XF, Duan XZ, Liu Y, Shi B, Zhang W, Wei LH, Belinson L, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct 25; 55(10):708-715. PubMed ID: 33120484
    [Abstract] [Full Text] [Related]

  • 6. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 7. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE.
    Cancer Epidemiol; 2009 Dec 02; 33(6):446-50. PubMed ID: 19931499
    [Abstract] [Full Text] [Related]

  • 8. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Dec 02; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 9. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M.
    CMAJ; 2000 Sep 05; 163(5):513-8. PubMed ID: 11006761
    [Abstract] [Full Text] [Related]

  • 10. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A.
    JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284
    [Abstract] [Full Text] [Related]

  • 11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 05; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, Nevarez PH, Acosta RD, Hernández-Avila M.
    Lancet; 2011 Nov 26; 378(9806):1868-73. PubMed ID: 22051739
    [Abstract] [Full Text] [Related]

  • 17. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct 18; 38(5):480-2. PubMed ID: 17068618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HPV testing with cytology triage for cervical cancer screening in routine practice.
    Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A.
    Am J Obstet Gynecol; 2014 May 18; 210(5):474.e1-7. PubMed ID: 24373948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.